Literature DB >> 12967564

Coordinate activation of maternal protein degradation during the egg-to-embryo transition in C. elegans.

Jason Pellettieri1, Valerie Reinke, Stuart K Kim, Geraldine Seydoux.   

Abstract

The transition from egg to embryo occurs in the absence of transcription yet requires significant changes in gene activity. Here, we show that the C. elegans DYRK family kinase MBK-2 coordinates the degradation of several maternal proteins, and is essential for zygotes to complete cytokinesis and pattern the first embryonic axis. In mbk-2 mutants, the meiosis-specific katanin subunits MEI-1 and MEI-2 persist during mitosis and the first mitotic division fails. mbk-2 is also required for posterior enrichment of the germ plasm before the first cleavage, and degradation of germ plasm components in anterior cells after cleavage. MBK-2 distribution changes dramatically after fertilization during the meiotic divisions, and this change correlates with activation of mbk-2-dependent processes. We propose that MBK-2 functions as a temporal regulator of protein stability, and that coordinate activation of maternal protein degradation is one of the mechanisms that drives the transition from symmetric egg to patterned embryo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12967564     DOI: 10.1016/s1534-5807(03)00231-4

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  60 in total

Review 1.  EGG molecules couple the oocyte-to-embryo transition with cell cycle progression.

Authors:  Jean M Parry; Andrew Singson
Journal:  Results Probl Cell Differ       Date:  2011

2.  The mbk-2 kinase is required for inactivation of MEI-1/katanin in the one-cell Caenorhabditis elegans embryo.

Authors:  Sophie Quintin; Paul E Mains; Andrea Zinke; Anthony A Hyman
Journal:  EMBO Rep       Date:  2003-11-21       Impact factor: 8.807

3.  Nup155 regulates nuclear envelope and nuclear pore complex formation in nematodes and vertebrates.

Authors:  Cerstin Franz; Peter Askjaer; Wolfram Antonin; Carmen López Iglesias; Uta Haselmann; Malgorzata Schelder; Ario de Marco; Matthias Wilm; Claude Antony; Iain W Mattaj
Journal:  EMBO J       Date:  2005-09-29       Impact factor: 11.598

4.  Spatial regulation of cytokinesis by the Kin1 and Pom1 kinases in fission yeast.

Authors:  Stéphanie La Carbona; Xavier Le Goff
Journal:  Curr Genet       Date:  2006-09-20       Impact factor: 3.886

5.  The Caenorhabditis elegans ekl (enhancer of ksr-1 lethality) genes include putative components of a germline small RNA pathway.

Authors:  Christian E Rocheleau; Kevin Cullison; Kai Huang; Yelena Bernstein; Annina C Spilker; Meera V Sundaram
Journal:  Genetics       Date:  2008-02-03       Impact factor: 4.562

6.  Inhibition of transcription by the Caenorhabditis elegans germline protein PIE-1: genetic evidence for distinct mechanisms targeting initiation and elongation.

Authors:  Dolan Ghosh; Geraldine Seydoux
Journal:  Genetics       Date:  2008-01       Impact factor: 4.562

7.  Polar gradients of the DYRK-family kinase Pom1 couple cell length with the cell cycle.

Authors:  Sophie G Martin; Martine Berthelot-Grosjean
Journal:  Nature       Date:  2009-05-27       Impact factor: 49.962

8.  In Vivo Interaction Proteomics in Caenorhabditis elegans Embryos Provides New Insights into P Granule Dynamics.

Authors:  Jia-Xuan Chen; Patricia G Cipriani; Desirea Mecenas; Jolanta Polanowska; Fabio Piano; Kristin C Gunsalus; Matthias Selbach
Journal:  Mol Cell Proteomics       Date:  2016-02-24       Impact factor: 5.911

9.  Global transcriptional repression in C. elegans germline precursors by regulated sequestration of TAF-4.

Authors:  Tugba Guven-Ozkan; Yuichi Nishi; Scott M Robertson; Rueyling Lin
Journal:  Cell       Date:  2008-10-03       Impact factor: 41.582

10.  MEG-1 and MEG-2 are embryo-specific P-granule components required for germline development in Caenorhabditis elegans.

Authors:  Stefanie W Leacock; Valerie Reinke
Journal:  Genetics       Date:  2008-01       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.